Earnings Ahead

IMAB - I-MAB

I-MAB

I-MAB

About

Profile


Headquarters

China


Intraday

High
-
Low
-

52-week

High
-
Low
-

IMAB



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • I-Mab Biopharma Non-GAAP EPADS of -$1.05 misses by $0.26, revenue of $2.7M misses by $0.3M
  • I-Mab Biopharma 1H 2023 Earnings Preview
  • I-Mab appoints Raj Kannan as CEO
  • Tracon stock slumps ~15% after I-Mab gets favorable ruling in arbitration
  • I-Mab Biopharma Non-GAAP EPADS of -$3.58 misses by $2.75, revenue of $32.1M misses by $69.23M
  • I-Mab Biopharma FY 2022 Earnings Preview
  • I-Mab gets Chinese nod to start phase 3 combo treatment trial for myelodysplastic syndrome
  • Tracon Pharmaceuticals announces $35M non-dilutive debt facility
  • I-Mab Biopharma Non-GAAP EPADS of -$1.54, revenue of $7.74M
  • I-Mab and senior executives may buy $40M worth of shares; stock up 10%
  • AbbVie to discontinue phase 1 trial for I-Mab's anti-CD47 therapy for treatment of cancers
  • I-Mab doses first patient in phase 1 trial of TJ-CD4B in solid tumors in China
  • Wuxi Biologics closer to get off U.S. 'unverified' trade list – Reuters
  • I-Mab completes enrollment in phase 3 trial to treat children with growth hormone deficiency
  • I-Mab, Ferring team up to develop olamkicept for inflammatory bowel disease
  • I-Mab draws mixed views at H.C. Wainwright after ASCO readout for lung cancer drug
  • I-Mab slips after announcing mid-stage data for CD73 antibody in lung cancer
  • I-Mab appointed industry veteran for COO role
  • Chinese biotech I-Mab spikes on report of buyout interest (updated)
  • I-Mab Biopharma Non-GAAP EPS of -$1.54 misses by $0.63, revenue of $13.8M misses by $70.64M

Earnings History

Date EPS / Forecast Revenue / Forecast
August 31, 2021 -0.9871 / -1.24 2.75M / - Beat!
June 2, 2021 -0.362 / -0.181 - / -
March 29, 2021 0.8548 / 1.66 238.55M / 201.05M Beat!
December 2, 2020 0.6973 / -0.57 - / -
August 31, 2020 -0.53 / -0.82 - / -
Date Price Open High Low Vol Change ER
Mar 16 16.73 16.24
17.20
16.24
324.28K 24.11%
Mar 15 13.48 12.01
14.42
12.00
1.64M 7.50%
Mar 14 12.54 15.00
15.00
12.45
3.40M -25.18%
Mar 11 16.76 18.95
18.95
16.50
1.35M -9.5%
Mar 10 18.52 18.97
19.80
17.50
1.47M -13.82%
 
Mar 9 21.49 20.88
21.65
20.38
233.63K 7.29%
Mar 8 20.03 20.81
21.03
18.01
733.44K -4.21%
Mar 7 20.91 20.88
22.13
20.21
842.89K -1.13%
Mar 4 21.15 22.91
22.91
20.29
1.39M -7.2%
Mar 3 22.79 25.70
26.11
22.00
761.01K -11.29%
Mar 2 25.69 26.11
26.15
24.60
652.52K -2.54%
Mar 1 26.36 24.99
26.75
24.93
775.43K 6.63%
Feb 28 24.72 24.37
25.86
24.08
603.61K -0.96%
Feb 25 24.96 25.53
25.96
23.95
703.00K -0.76%
Feb 24 25.15 22.89
25.32
22.68
831.24K 4.53%
Feb 23 24.06 26.00
26.57
23.85
360.59K -4.9%
Feb 22 25.30 26.09
26.80
24.89
433.65K -5.31%
Feb 18 26.72 27.14
27.98
25.68
447.40K -3.78%
Feb 17 27.77 28.73
29.60
27.32
798.18K -3.78%
Feb 16 28.86 28.00
29.20
27.26
1.13M 3.74%